SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 7.75 |
| Enterprise Value ($M) | 8.57 |
| Book Value ($M) | 0.41 |
| Book Value / Share | 0.13 |
| Price / Book | 18.88 |
| NCAV ($M) | -0.31 |
| NCAV / Share | -0.10 |
| Price / NCAV | -25.14 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.62 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | -5.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.15 |
| Current Ratio | 0.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.66 |
| Assets | 2.38 |
| Liabilities | 1.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3.11 |
| Operating Income | -0.18 |
| Net Income | -0.84 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.28 |
| Cash from Investing | 0.00 |
| Cash from Financing | -0.19 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| HNSPF – Hansoh Pharmaceutical Group Company Limited | HSTC – HST Global, Inc. |
| HSTOQ – Histogen Inc. | IAGX – Imagenetix, Inc. |
| IGXT – IntelGenx Technologies Corp. |
Financial data and stock pages provided by
Fintel.io